New 280,000 square foot Kornberg Center accelerates scientific exploration and engages sustainability best practices Madison, WI USA. Promega Corporation today announced the opening of Kornberg Center, the biotech company’s newly constructed research and development facility on its Fitchburg, WI campus. The three-story, 280,000-square-foot building, named for Nobel Prize-winning biochemist Arthur Kornberg, will support core product […]
GeneMill at the University of Liverpool receives first benchtop Onyx platform in Europe Financing round led by Fidelity and T. Rowe Price funds underscores vast opportunities to bring Inscripta’s CRISPR-based technology to the broader bioeconomy Inscripta, Inc., the digital genome engineering company, today announced the first commercial shipment of its Onyx™ platform and the closing of […]
DURHAM, N.C.– BioSkryb, Inc., today announced the expansion of the company’s leadership team with the appointment of Sean Keohane as Senior Vice President of Commercial Operations. Keohane has more than 25 years of experience in life science product commercialization, with demonstrated success in building strong teams and implementing strategic plans to capture market share and […]
Along with recent release of CellPlex, product increases access through affordability PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG) today announced the launch of its Chromium Single Cell Gene Expression Low Throughput (LT) Kit, a new offering designed to put the power of single cell analysis within the reach of more scientists than ever before. […]
HERCULES, Calif. —Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two products for the Droplet Digital PCR (ddPCR) platforms. The ddPCR Assays for AAV Viral Titer and the Vericheck ddPCR Mycoplasma Detection Kit support the development and manufacture of safe and effective cell and gene therapies. Accurate […]
Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces a new contract with the Institute of Immunology and Genetics (‘IIG’ or the ‘Institute’) a leading molecular genetic laboratory in Kaiserslautern, Germany, equipped with state-of-the-art equipment and comprehensive human genetic and bioinformatic expertise. From analysis […]
· Agilent Technologies to manufacture custom microarray based on OBD’s proprietary probe sets for EpiSwitch® Explorer Array Kit · First commercial microarray kit available for high-resolution 3D genome profiling and biomarker discovery · Kit accompanied by EpiSwitch® Data Portal to enable powerful, intuitive analytics of research data and access to 3D genome knowledgebase · Launch of the EpiSwitch® Explorer Array Kit […]
The Swedish AI software company Qlucore AB (“Qlucore” or “the Company”) – with more than 200 international customers – today announces that it has secured SEK 30 million before transaction costs in a pre-IPO private placement. The raised capital will predominantly be used to accelerate sales activities and expand the technical team prior to an […]
Partnership combines Viroclinics-DDL’s diagnostic and high-throughput sequencing experience with ENPICOM’s expertise in bioinformatics and immunomics ‘s-Hertogenbosch (The Netherlands) – Life Science Newswire – Viroclinics-DDL, a state-of-the-art Contract Research Organization specialized in molecular diagnostic testing and assay development, and ENPICOM, an innovative bioinformatics software engineering company, announced the approval of their joint MIT Zuid subsidy (SME […]
IP Group plc (LSE: IPO) (“IP Group” or “the Group”), the developer of intellectual property-based businesses, notes that portfolio company Oxford Nanopore Technologies Ltd (“Oxford Nanopore”) has today announced that it has informed its shareholders that it has started the process of preparing for a potential Initial Public Offering (“IPO”). Whilst the timing of a potential […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
